Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacira Pharmaceuticals

25.42
-0.5500-2.12%
Post-market: 25.420.00000.00%18:22 EDT
Volume:552.14K
Turnover:14.14M
Market Cap:1.18B
PE:-11.21
High:26.30
Open:26.16
Low:25.36
Close:25.97
Loading ...

Pacira price target raised to $24 from $17 at Barclays

TIPRANKS
·
01 Mar

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus

Zacks
·
01 Mar

Stock Track | Pacira Pharmaceuticals Plummets 5% as Commercial and Pipeline Execution Uncertainty Weighs on Outlook

Stock Track
·
01 Mar

Q4 2024 Pacira Biosciences Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

RBC Capital Adjusts Pacira Biosciences Price Target to $22 From $18, Maintains Sector Perform Rating

MT Newswires Live
·
28 Feb

Pacira BioSciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
28 Feb

Pacira Biosciences Inc : Needham Raises Target Price to $32 From $30

THOMSON REUTERS
·
28 Feb

Pacira Pharmaceuticals: Undervalued with Strong Growth Potential and Legal Protections Against Generic Competition

TIPRANKS
·
28 Feb

Pacira Biosciences, Inc. : H.c. Wainwright Raises Target Price to $48 From $39

THOMSON REUTERS
·
28 Feb

Pacira BioSciences Inc (PCRX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

GuruFocus.com
·
28 Feb

Pacira BioSciences Buys Remaining 81% Stake of GQ Bio Therapeutics

Dow Jones
·
28 Feb

Pacira (PCRX) Tops Q4 Earnings Estimates

Zacks
·
28 Feb

Pacira: Q4 Earnings Snapshot

Associated Press Finance
·
28 Feb

Pacira Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Pacira reports Q4 non-GAAP EPS 96c, consensus 83c

TIPRANKS
·
28 Feb

Pacira BioSciences Q4 Adj $0.91 Beats $0.84 Estimate, Sales $187.25M Beat $184.36M Estimate

Benzinga
·
28 Feb

BRIEF-Pacira Biosciences FY Adjusted EBITDA USD 224 Million Vs. IBES Estimate USD 222 Million

Reuters
·
28 Feb

Pacira Biosciences Inc: Qtrly EPS $0.34

THOMSON REUTERS
·
28 Feb

Pacira Biosciences Inc Outlook FY Total Revenue of $725 Mln to $765 Mln

THOMSON REUTERS
·
28 Feb

Pacira Biosciences Inc - Reports Q4 Revenues of $187.3 Million

THOMSON REUTERS
·
28 Feb